tiprankstipranks
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
ENSC
Ensysce Biosciences
RESEARCH TOOLSreports
Want to see ENSC full AI Analyst Report?

Ensysce Biosciences (ENSC) Ratios

303 Followers

Ensysce Biosciences Ratios

ENSC's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, ENSC's free cash flow was decreased by $ and operating cash flow was $-1.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.59 1.59 2.42 0.69 0.56
Quick Ratio
 1.59 1.59 2.42 0.69 0.56
Cash Ratio
 943.65K 0.94 1.59 0.34 0.33
Solvency Ratio
 -1.03 >-0.01 -3.60 -3.16 -2.44
Operating Cash Flow Ratio
 -1.71 -1.71 -3.40M -3.23 -1.89
Short-Term Operating Cash Flow Coverage
 >-0.01 -25.45 -24.87M -12.61 -4.19
Net Current Asset Value
$ 2.67M$ 2.67T$ 3.13M$ -1.07M$ -4.62M
Leverage Ratios
Debt-to-Assets Ratio
 41.16K 0.04 0.05 0.32 0.75
Debt-to-Equity Ratio
 95.44K 0.10 0.08 -2.65 -1.19
Debt-to-Capital Ratio
 1.00 0.09 0.08 1.61 6.16
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 -0.04
Financial Leverage Ratio
 2.32 2.32 1.51 -8.39 -1.58
Debt Service Coverage Ratio
 >-0.01 >-0.01 -4.23 -8.87 -5.54
Interest Coverage Ratio
 -545.72 -545.69 -5.22 -30.28 -221.16
Debt to Market Cap
 84.98K 130.38K 0.02 0.02 0.18
Interest Debt Per Share
 119.95K 119.95K 0.91 0.53 25.25
Net Debt to EBITDA
 854.34K 394.41K 0.48 0.03 -0.05
Profitability Margins
Gross Profit Margin
-33.43%0.00%-38.57%-240.12%-686.08%
EBIT Margin
-200.88%-200.48%-129.17%-480.41%-959.91%
EBITDA Margin
-92.49%-200.35%-129.17%-480.41%-959.90%
Operating Profit Margin
-202.13%-202.12%-129.17%-480.41%-959.91%
Pretax Profit Margin
-200.85%-200.85%-153.30%-476.29%-959.33%
Net Profit Margin
-200.85%-200.84%-153.30%-475.71%-957.93%
Continuous Operations Profit Margin
-200.85%-200.85%-153.30%-476.29%-959.33%
Net Income Per EBT
100.00%100.00%100.00%99.88%99.85%
EBT Per EBIT
99.36%99.37%118.68%99.14%99.94%
Return on Assets (ROA)
-136.55%>-0.01%-142.70%-391.90%-410.74%
Return on Equity (ROE)
-374.98%>-0.01%-215.37%3287.20%650.76%
Return on Capital Employed (ROCE)
-355.02%>-0.01%-198.52%1715.21%676.75%
Return on Invested Capital (ROIC)
>-0.01%>-0.01%-182.30%-4663.69%-3388.81%
Return on Tangible Assets
-136.55%>-0.01%-142.70%-391.90%-410.74%
Earnings Yield
-1101.50%-432.56%-56.17%-29.48%-99.51%
Efficiency Ratios
Receivables Turnover
 12.05 12.05 41.98 22.87 9.12
Payables Turnover
 1.49 0.00 5.32 3.92 6.74
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 24.13 <0.01 0.00 0.00 0.00
Asset Turnover
 0.68 <0.01 0.93 0.82 0.43
Working Capital Turnover Ratio
 3.07 <0.01 4.98 -0.86 -1.01
Cash Conversion Cycle
 -214.23 30.28 -59.92 -77.18 -14.13
Days of Sales Outstanding
 30.28 30.28 8.70 15.96 40.04
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 244.51 0.00 68.62 93.14 54.17
Operating Cycle
 30.28 30.28 8.70 15.96 40.04
Cash Flow Ratios
Operating Cash Flow Per Share
 -3.05 -3.05M -4.29M -4.76 -99.41
Free Cash Flow Per Share
 -3.10 -3.05M -4.29M -4.76 -99.41
CapEx Per Share
 0.05 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.02 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -63.14 0.00 -25.87K 0.00 0.00
Capital Expenditure Coverage Ratio
 -63.14 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 >-0.01 -25.45 -24.87M -12.61 -4.03
Operating Cash Flow to Sales Ratio
 -1.54 -1.54M -1.44M -4.83 -7.09
Free Cash Flow Yield
-236.57%-331838091.51%-52759451.44%-29.95%-73.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.10 -0.23 -1.78 -3.39 -1.00
Price-to-Sales (P/S) Ratio
 0.71 0.46 2.73 16.14 9.63
Price-to-Book (P/B) Ratio
 0.31 <0.01 3.83 -111.50 -6.54
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.46 >-0.01 >-0.01 -3.34 -1.36
Price-to-Operating Cash Flow Ratio
 -0.13 >-0.01 >-0.01 -3.34 -1.36
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.02 0.70 0.04 0.02
Price-to-Fair Value
 0.31 <0.01 3.83 -111.50 -6.54
Enterprise Value Multiple
 854.34K 394.41K -1.64 -3.33 -1.06
Enterprise Value
 -4.00T -4.00T 11.02M 35.73M 25.58M
EV to EBITDA
 854.34K 394.41K -1.64 -3.33 -1.06
EV to Sales
 -790.20K -790.20K 2.12 16.01 10.14
EV to Free Cash Flow
 504.88K 0.51 >-0.01 -3.31 -1.43
EV to Operating Cash Flow
 512.87K 0.51 >-0.01 -3.31 -1.43
Tangible Book Value Per Share
 1.13 1.13M 1.93 -0.29 -22.40
Shareholders’ Equity Per Share
 1.26 1.26M 2.12 -0.14 -20.64
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 1.98 1.98 2.98 0.99 14.02
Net Income Per Share
 -3.98 -3.98 -4.57 -4.69 -134.34
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.19 0.99 1.00
Research & Development to Revenue
 2.05 2.05M 1.39 3.40 7.86
SG&A to Revenue
 973.17K 973.17K 0.91 2.40 2.74
Stock-Based Compensation to Revenue
 0.11 131.98K 21.25K 0.39 0.42
Income Quality
 0.60 0.77 939.36K 1.01 0.74
Currency in USD